[Clinical efficacy and outcome of endovascular therapy for complex arteriosclerosis obliterans of the lower extremities]

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Oct;42(10):831-4.
[Article in Chinese]

Abstract

Objective: To evaluate efficacy and outcome of endovascular therapy for complex arteriosclerosis obliterans of the lower extremities.

Methods: In this single-center retrospective study, the clinical data of consecutive 114 cases with TASC II type C/D lower extremity obstructive disease and clinical stage of Fontaine ≥ IIb and ankle brachial index <0.9 underwent endovascular therapy from December 2011 to January 2013 were collected. Telephone or clinic interviews were conducted to investigate the clinical outcomes.

Results: There were 39 TASC II type C patients and 75 TASC II type D patients, 78 patients were in Fontaine IIb, 30 patients in Fontaine III and 6 patients in Fontaine IV stages. Immediate procedural success rate was 94.9% (131/138). Ankle brachial index was increased from 0.54 ± 0.26 at baseline to 0.83 ± 0.30 at discharge (P < 0.01). No adverse event was observed during the perioperative period. During (15.7 ± 8.7) months follow-up, cumulative patency rate of 6, 12 and 18 months was 75.8% (94/124) , 68.7% (68/99) and 39.2% (20/51) respectively and limb salvage rate was 100%.

Conclusion: Endovascular therapy for complex arteriosclerosis obliterans of the lower extremities is effective and safe.

MeSH terms

  • Ankle Brachial Index
  • Arteriosclerosis Obliterans / therapy*
  • Femoral Artery
  • Humans
  • Limb Salvage*
  • Lower Extremity
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome